Value of covered stents to improve patency of long-segment SFA revascularization
1Department of Angiology, University-Heart Center Freiburg-Bad Krozingen, Germany - ulrich.beschorner@herzzentrum.de.
Insights
Endovascular treatment for long femoropopliteal lesions shows promising results. The Viabahn endoprosthesis offers sustainable patency, potentially surpassing traditional surgical bypass methods.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Biomedical Engineering
Background:
- Endovascular treatment is now a primary strategy for revascularizing complex femoropopliteal lesions.
- There is a growing demand for endovascular techniques that ensure long-term patency.
- Traditional surgical bypass procedures often utilize prosthetic materials.
Purpose of the Study:
- To evaluate the efficacy and patency rates of the Viabahn endoprosthesis for femoropopliteal lesions.
- To compare the performance of the Viabahn endoprosthesis against conventional surgical bypass.
Main Methods:
- Review of recently published clinical trials.
- Analysis of patency data for endovascular repair using the Viabahn endoprosthesis.
- Comparison of outcomes with surgical bypass procedures.
Main Results:
- The Viabahn endoprosthesis demonstrated promising patency rates in recent trials.
- Patency rates achieved with the Viabahn endoprosthesis were comparable or superior to surgical bypass.
- Viabahn endoprosthesis shows potential for sustainable success in complex lesion treatment.
Conclusions:
- Endovascular treatment with the Viabahn endoprosthesis is a viable and effective option for femoropopliteal lesions.
- The Viabahn endoprosthesis offers competitive or improved patency compared to surgical bypass.
- Further research supports endovascular approaches for improved patient outcomes.
Abstract:
Endovascular treatment has become first-line approach for revascularization of long and complex femoropopliteal lesions in many centers. This development urges the need for endovascular approaches with a sustainable success in terms of patency. In several recently published trials the Viabahn® endoprosthesis by Gore (W.L. Gore Inc, Flagstaff, AZ, USA) has shown promising patency rates comparable or even better than traditional surgical bypass procedures with prosthetic material.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care

